Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) Trading Down 21.8% – Time to Sell?

Shares of Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) fell 21.8% during mid-day trading on Thursday . The company traded as low as $2.84 and last traded at $2.84. 1,200 shares were traded during trading, a decline of 66% from the average session volume of 3,524 shares. The stock had previously closed at $3.63.

Analyst Ratings Changes

Separately, Pareto Securities cut Surgical Science Sweden AB (publ) to a “hold” rating in a research report on Wednesday, November 26th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock currently has an average rating of “Hold”.

Surgical Science Sweden AB (publ) Stock Down 21.8%

The company’s fifty day simple moving average is $3.46 and its 200 day simple moving average is $7.49.

About Surgical Science Sweden AB (publ)

Surgical Science Sweden AB (publ) develops and markets virtual reality–based medical simulation solutions designed to train healthcare professionals in minimally invasive surgical techniques. Headquartered in Gothenburg, Sweden, the company leverages advanced haptic feedback and three-dimensional graphics to create realistic, interactive scenarios for a range of surgical disciplines, including laparoscopy, endoscopy and arthroscopy. Its platform allows trainees to practice complex procedures in a risk-free environment, helping to improve precision and reduce the learning curve for both trainees and experienced practitioners adapting to new technologies.

The company’s product portfolio includes LapSim for basic and advanced laparoscopic skills, EndoSim for gastrointestinal endoscopy, ArthroSim for diagnostic and therapeutic arthroscopy, as well as modules for vascular and bronchial interventions.